An online survey conducted by FDA researchers found that while health care providers’ (HCPs’) perceptions and intentions are not swayed by the industry representative credentials, data limitation disclosures can temper their perceptions of drugs promoted at medical conferences. An upcoming article in the Journal of the American Board of Family Medicine detailed the results of... Read More